Success Metrics

Active Trials
2(22%)

Phase Distribution

Ph phase_3
3
33%
Ph phase_2
6
67%

Phase Distribution

0

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
6(66.7%)
Phase 3Large-scale testing
3(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Terminated(1)
Other(4)

Detailed Status

unknown4
Not yet recruiting2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 26 (66.7%)
Phase 33 (33.3%)

Trials by Status

not_yet_recruiting222%
recruiting222%
unknown444%
withdrawn111%

Recent Activity

2 active trials
Showing 5 of 9
withdrawnphase_2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

NCT06501989
recruitingphase_3

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

NCT05008809
recruitingphase_2

Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer

NCT05571644
not_yet_recruitingphase_3

Pre-Operative Treatment in REseCTable COlon CanceR

NCT06899477
not_yet_recruitingphase_3

Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)

NCT05427669
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06501989Phase 2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Withdrawn
NCT05008809Phase 3

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

Recruiting
NCT05571644Phase 2

Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer

Recruiting
NCT06899477Phase 3

Pre-Operative Treatment in REseCTable COlon CanceR

Not Yet Recruiting
NCT05427669Phase 3

Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)

Not Yet Recruiting
NCT05200299Phase 2

mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Unknown
NCT03603834Phase 2

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Unknown
NCT04423965Phase 2

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

Unknown
NCT04170530Phase 2

Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9